University of Queensland
University of Queensland researchers have received $2 million from the National Health and Medical Research Council to improve understanding of prostrate and breast cancer and expedite the translation of research outcomes.
The Development Grants scheme funds early-stage health and medical projects with a clear path to commercialisation and strong potential for intellectual property.
NHMRC Development Grants recipients:
Professor Gregory Monteith - improve a leading therapy for the treatment of advanced and refractory prostate cancer.
Associate Professor David Muller - develop needle-free mRNA vaccines for the protection from and treatment of HER2+ breast cancer.
/Public Release. View in full here.
